Articles

Case study:  New technology in COVID research may accelerate vaccines

5 February 2021

By Lance Wells, Co-Director of the Thermo Fisher appointed Center of Excellence in Glycoproteomics at the CCRC at the University of Georgia. As we race to combat the COVID-19 pandemic, time is of the essence. Technological advancements are required to understand the behaviour of the COVID molecule to develop vaccines that will prevent the virus, […]

Vaccine success sends business confidence to a six-year high

4 February 2021

UK businesses can now look forward to the easing of restrictions and pent-up demand as vaccine boosts confidence. Luke Davis, CEO of IW Capital, comments on the success of the vaccine and how it will impact businesses and future investments in the UK. The recent success of the UK vaccine roll-out has sent business confidence […]

Using digital technology to solve compound management problems

28 January 2021

Managing Director of Ziath, Neil Benn MSc, explains to Lu Rahman how the latest mobile and internet-enabled technologies will impact the science of compound management. Ziath is a UK-based company specialising in design, development and production of instrumentation for sample management. Ziath’s primary product range is 2D barcode scanners for tubes held in racks supported […]

Affinity maturation of a GPCR binder using self-labelling antibody discovery platform

28 January 2021

This paid-for advertorial by OXGENE appeared in DDW Volume 22, Issue 1 – Winter 2020/21 Identification and affinity maturation of antibodies against membrane proteins in their native configuration remains challenging. Here, OXGENE uses its SLIM display antibody discovery platform for an affinity maturation project using a parental antibody against a GPCR target from DJS Antibodies. […]

Sitting down with…CN Bio

28 January 2021

CN Bio is a cell culture company whose mission is to transform the way human-relevant pre-clinical data is generated by developing the most complete model of the human ‘body-on-a-chip’ in the laboratory.  Achieving this is what drives the company’s future initiatives, CEO Dr David Hughes told Lu Rahman. CN Bio hit its first major milestone […]

Digital focus: Proteomics – why proteins matter

28 January 2021

Lu Rahman looks at the rise of proteomics, its growing role in the quest for new treatments and some of the work being carried out in this field. Due to the introduction of technology-enabled proteomics products, the global proteomics market is expected to reach $24.8 billion by 2024, says Grand View Research. It notes that these […]

Old wine in new bottles: low-tech approaches to a COVID-19 vaccine

27 January 2021

By David Berd, Chief Medical Officer, BioVaxys. It has been a little more than a year since COVID-19 was released on the world causing widespread respiratory illness, death and major disruptions in the world’s economies and in people’s daily lives.  From the beginning of the pandemic, it was recognised that a vaccine that prevented the acquisition […]

DDW App note: Implementation and evaluation of SARS-CoV-2 detection assay

27 January 2021

This paid-for app note by Analytik Jena appeared in DDW Volume 22, Issue 1 – Winter 2020/ 21. December 2019 the novel SARS-CoV-2 (formerly named 2019-nCoV) was identified in Wuhan, the capital of China’s province Hubei. Based on its rapid spreading with more than 950,000 confirmed cases by the beginning of April 2020 the World Health […]

IDMP data standards – what next in 2021?

26 January 2021

Against the backdrop of COVID-19 disruption, there has been good progress made with European IDMP data standards. Remco Munnik of Iperion Life Sciences Consultancy looks back at the main IDMP developments in 2020 – and looks ahead to a future better supported by data standardisation. The COVID-19 pandemic has highlighted the potential for global data […]

DDW App Note: The ZE5 Cell Analyzer in the fight against COVID-19

26 January 2021

This paid-for app note by Bio-Rad appeared in DDW Volume 22, Issue 1 – Winter 2020/21. As COVID-19 has taken the world by storm, much has been learnt about the various aspects of viral infections ranging from immune surveillance to the therapeutic development of vaccines. One of the technologies that has played a large part in […]

« Previous
Next »

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free